Role of saraswata churna in anxiety disorder which is seen in Diabetes mellitus

â?? EFFICACY OF SARASWATA CHURNA IN ANXIETY DISORDER (CHITTODVEGA) IN DIABETES MELLITUSâ??

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/035102

Enrollment

Registered

2021-07-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications Health Condition 2: F411- Generalized anxiety disorder

Interventions

Intervention1: SARASWATA CHURNA: Saraswata churna-Kustha, ashwagandhÄ?,lavana(saindhava) ajamodÄ?,jiraka,trikatu,pathÄ?, sankhapushpi_all equal parts and vacÄ? equal to the total of all the above drug

the procedure is repeated thrice. This powder, one akÅ?a (10gms.) in quanity is taken with goghrita Saraswata churna Given for 90 days in duration of (1st,15,30,60,90 days)of follow up Control Inte

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients from age group of 18 to 70 years, irrespective of gender, religion, occupation, economic status. 2. Patients selected with known case of DM with anxiety disorder (chittodvega). 3. Diabetes Patient with Mild Anxiety Disorder (as per Hamilton Anxiety Scale).

Exclusion criteria

Exclusion criteria: 1.Patient with Known case of Ischemic Heart Disease, known case of Cerebrovascular accident. 2. Patient with Known cases of Brain disorders i.e. tumour, Carcinoma of brain, seizures 3.Known cases of Chronic Depression (more than one year). 4.Known cases of severe illness. 5.Diabetic complications Neuropathy, Retinopathy, Nephropathy etc 6.Uncontrolled Diabetes. 7.Suicidal Tendency

Design outcomes

Primary

Measure	Time frame
Saraswata churna is effective in the treatment of anxiety disorder (chittodvega) in diabetes mellitus patients . Measured by subjective parameters, and Hamilton Anxiety ScaleTimepoint: 3 month follow up ( 0 , 15th , 30th, 60th, 90th day)	—

Secondary

Measure	Time frame
Saraswata churna is beneficial in the management of anxiety disorder (chittodvega) in diabetes mellitus type 2 patientsTimepoint: 3 month follow up ( 0 , 15th , 30th, 60th, 90th day)	—

Countries

India

Contacts

Public ContactDr SUNANDA PEDHEKAR GHARE

Bharati vidyapeeth deemed to be university College of ayurveda and hospital, katraj pune

drsrpedhekar@gmail.com9325915438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026